Literature DB >> 29656979

Reducing Length of Stay Does Not Increase Emergency Room Visits or Readmissions in Patients Undergoing Primary Hip and Knee Arthroplasties.

Andrea H Stone1, Leah Dunn1, James H MacDonald2, Paul J King3.   

Abstract

BACKGROUND: Total hip and total knee arthroplasty (total joint arthroplasty [TJA]) are 2 of the most common elective surgeries. Identifying which patients are at highest risk for emergency room (ER) visits or readmissions within 90 days of surgery and the reasons for return are crucial to formulate ways to decrease these visits and improve patient outcomes.
METHODS: This is a retrospective review of a consecutive series of 7466 unilateral primary TJA performed from July 2013 to June 2017; any patients who had an ER visit or readmission in the first 90 days after surgery were identified, and a detailed chart review was performed. Patients discharged home or to rehab were analyzed separately.
RESULTS: Three hundred thirty-six (4.5%) patients had 380 ER visits and 250 (3.3%) patients had 291 readmissions in the first 90 days after TJA. Patients returning to the ER were equivalent to those who did not. Patients who went to a rehab facility on discharge were significantly more likely to be readmitted (P = .000). Patients who were readmitted had a higher American Society of Anesthesiologists score (P = .000). Length of stay decreased over the study period from 2.66 days to 1.63 days, while the number of unplanned interventions remained steady. Pain and swelling was the most common reason for return for ER visits (33.2%) and readmissions (14.1%).
CONCLUSION: The overall number of unplanned interventions after TJA in this population was low and remained consistent over time despite decreasing length of stay. Patients who went to rehab were more likely to experience readmission. The majority of unplanned interventions occurred in the first 4 weeks after surgery.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  emergency room visit; length of stay; readmission; total hip arthroplasty; total knee arthroplasty

Mesh:

Year:  2018        PMID: 29656979     DOI: 10.1016/j.arth.2018.03.043

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  A Rapid Recovery Protocol Applied to Total Joint Arthroplasty Reduced Readmissions for Surgical but Not Medical Reasons Over a 5-Year Period.

Authors:  Justin Turcotte; Nandakumar Menon; Jeanne Angeles; Amina Zaidi; Paul King; James MacDonald
Journal:  HSS J       Date:  2021-03-23

2.  Modifiable, Postoperative Risk Factors for Delayed Discharge Following Total Knee Arthroplasty: The Influence of Hypotension and Opioid Use.

Authors:  Albert T Anastasio; Kevin X Farley; Scott D Boden; Thomas L Bradbury; Ajay Premkumar; Michael B Gottschalk
Journal:  J Arthroplasty       Date:  2019-08-08       Impact factor: 4.757

3.  Characterization of Re-admission and Emergency Department Visits Within 90 Days Following Lower-Extremity Arthroplasty.

Authors:  Elina Huerfano; Alejandro Gonzalez Della Valle; Kate Shanaghan; Federico Girardi; Stavros Memtsoudis; Jiabin Liu
Journal:  HSS J       Date:  2018-08-29

4.  Length of Stay After Joint Arthroplasty is Less Than Predicted Using Two Risk Calculators.

Authors:  Colin J Carr; Simon C Mears; C Lowry Barnes; Jeffrey B Stambough
Journal:  J Arthroplasty       Date:  2021-04-21       Impact factor: 4.435

5.  Fixation vs Arthroplasty for Femoral Neck Fracture in Patients Aged 40-59 Years: A Propensity-Score-Matched Analysis.

Authors:  Jacob M Wilson; Corey A Jones; Jeffrey Scott Holmes; Kevin X Farley; Roberto C Hernandez-Irizarry; Thomas J Moore; Thomas L Bradbury; George N Guild
Journal:  Arthroplast Today       Date:  2022-03-20

6.  Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension.

Authors:  Mikaela Wardle; Amanda Nair; Sarah Saunders; Iain Armstrong; Athanasios Charalampopoulos; Charlie Elliot; Abdul Hameed; Neil Hamilton; John Harrington; Carol Keen; Robert Lewis; Ian Sabroe; A A Roger Thompson; Robert M Kerry; Robin Condliffe; David G Kiely
Journal:  Pulm Circ       Date:  2022-03-25       Impact factor: 2.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.